Eli Lilly released a press release last week reporting on data from experience of Alimta treatment of mesothelioma. Now that the medicine has been on the market and available to a large portion of patients for a couple years, there is good evidence that it helps extended life expectancies. Lilly has also applied for European approval of Alimta.